{"filing":{"accession_number":"0001193125-26-259877","cik":"0001162194","ticker":"LAB","company_name":"STANDARD BIOTOOLS INC.","form":"8-K","filing_date":"2026-06-05","report_date":null,"primary_document":"d309595d8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1162194/000119312526259877/d309595d8k.htm"},"events":[{"id":6523,"run_id":5709,"accession_number":"0001193125-26-259877","anchor_item_number":"8.01","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.85,"summary":"The filing discloses that Standard BioTools has regained compliance with Nasdaq's minimum bid price requirement (Rule 5450(a)(1)) after previously falling below $1.00 per share for 30 consecutive business days on April 20, 2026. While the current disclosure is positive (resolution of the delisting risk), the underlying event—the prior non-compliance notice and threat of delisting—is material to investors and directly relates to the delisting_risk category. The company's ability to maintain listing is a fundamental concern for equity investors.","company_name":"STANDARD BIOTOOLS INC.","ticker":"LAB","filing_date":"2026-06-05","submitted_at":null,"items":[{"id":4944,"accession_number":"0001193125-26-259877","item_number":"8.01","item_title":"Other Events.","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.85,"reasoning":"The filing discloses that Standard BioTools has regained compliance with Nasdaq's minimum bid price requirement (Rule 5450(a)(1)) after previously falling below $1.00 per share for 30 consecutive business days on April 20, 2026. While the current disclosure is positive (resolution of the delisting risk), the underlying event—the prior non-compliance notice and threat of delisting—is material to investors and directly relates to the delisting_risk category. The company's ability to maintain listing is a fundamental concern for equity investors.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-05T21:04:02.232804+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":4944,"accession_number":"0001193125-26-259877","item_number":"8.01","item_title":"Other Events.","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.85,"reasoning":"The filing discloses that Standard BioTools has regained compliance with Nasdaq's minimum bid price requirement (Rule 5450(a)(1)) after previously falling below $1.00 per share for 30 consecutive business days on April 20, 2026. While the current disclosure is positive (resolution of the delisting risk), the underlying event—the prior non-compliance notice and threat of delisting—is material to investors and directly relates to the delisting_risk category. The company's ability to maintain listing is a fundamental concern for equity investors.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-05T21:04:02.232804+00:00","company_name":"STANDARD BIOTOOLS INC.","ticker":"LAB","filing_date":"2026-06-05"}]}